
Bivatuzumab
CAS No. 214559-60-1
Bivatuzumab( —— )
Catalog No. M36909 CAS No. 214559-60-1
Bivatuzumab (BIWA 4) is a humanized monoclonal antibody against CD44v6.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 375 | Get Quote |
![]() ![]() |
5MG | 615 | Get Quote |
![]() ![]() |
10MG | 938 | Get Quote |
![]() ![]() |
25MG | 1408 | Get Quote |
![]() ![]() |
50MG | 1822 | Get Quote |
![]() ![]() |
100MG | 2502 | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameBivatuzumab
-
NoteResearch use only, not for human use.
-
Brief DescriptionBivatuzumab (BIWA 4) is a humanized monoclonal antibody against CD44v6.
-
DescriptionBivatuzumab (Anti-CD44 Recombinant Antibody; BIWA 4) is a humanized monoclonal antibody directed against CD44v6. CD44v6 could acts as a sarcoma target for CAR-redirected CIK cells.
-
In VitroBivatuzumab (10 μg/mL) stains CD44v6 in STS cells.
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number214559-60-1
-
Formula Weight
-
Molecular Formula——
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Leuci V,et al. CD44v6 as innovative sarcoma target for CAR-redirected CIK cells. Oncoimmunology. 2018 Feb 15;7(5):e1423167. ?
molnova catalog



related products
-
Macrocarpal N
Macrocarpal N is a natural product of Eucalyptus, Myrtaceae. Macrocarpal N can be used as a reference standard.
-
Prenyletin
Prenyletin is a natural product found in the multilobed bimodal, multihorned pterosaurs.
-
FATP1-IN-1
FATP1-IN-1 is a potent inhibitor of fatty acid transport protein 1 (FATP1). It effectively inhibits the activity of recombinant human or mouse acyl-CoA synthetase, which is essential for the function of FATP1.